Executives On The Move: Comings And Goings At MorphoSys And PDL BioPharma, Along With Board Changes At Entasis And Sutro
Executive Summary
A new CEO will join MorphoSys AG and the CFO of PDL BioPharma is set to depart. Also, precision antibacterial company Entasis Therapeutics and cancer and autoimmune therapy firm Sutro Biopharma each elect a Chairman.